enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Abrocitinib - Wikipedia

   en.wikipedia.org/wiki/Abrocitinib

   In the EU, abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy. [9]In the US, abrocitinib is indicated for the treatment of people twelve years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics ...

3. Atopic dermatitis - Wikipedia

   en.wikipedia.org/wiki/Atopic_dermatitis

   Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. [2] Atopic dermatitis is also often called simply eczema but the same term is also used to refer to dermatitis, the larger group of skin conditions. [2] [5] Atopic dermatitis results in itchy, red, swollen, and cracked skin. [2]

4. Crisaborole - Wikipedia

   en.wikipedia.org/wiki/Crisaborole

   In the US, crisaborole is indicated for topical treatment of mild to moderate atopic dermatitis in people three months of age and older. [2]In the EU, crisaborole was authorized for treatment of mild to moderate atopic dermatitis in people two years of age and older with ≤ 40% body surface area (BSA) affected.

5. ASLAN Pharmaceuticals Presents New Data From Atopic ... - AOL

   www.aol.com/aslan-pharmaceuticals-presents-data...

   The company noted the new translational data presented at ESDR provide novel and differentiated mechanistic insights into IL-13Rα1 mediated cytokine signaling in atopic dermatitis (AD).

6. Tofacitinib - Wikipedia

   en.wikipedia.org/wiki/Tofacitinib

   New studies are exploring its safety profile, expanding indications (such as ankylosing spondylitis and atopic dermatitis), and comparing it with other treatments. Ongoing research also focuses on optimizing dosage and evaluating combination therapies. For the latest findings, consult recent peer-reviewed studies and clinical guidelines. [39]

7. Topical glucocorticoids - Wikipedia

   en.wikipedia.org/wiki/Topical_glucocorticoids

   Topical glucocorticoid phobia is a concern or fear about using topical glucocorticoids, which is commonly found among patients with atopic dermatitis and their caregivers. [29] This phenomenon has been identified in more than 15 countries globally, including Canada, France, Japan, the United Kingdom, and the United States. [30]